News | February 28, 2024
Bristol Myers Squibb inaugurates new US$100 million facility in Hyderabad
The facility will accommodate over 1,500 employees
The facility will accommodate over 1,500 employees
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Varenicline is indicated for smoking cessation in adults
Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
_Rupak_Singla_256_384.jpg)
Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
Subscribe To Our Newsletter & Stay Updated
